Don't forget the royalty and milestones payments to Brickell, they're not insignificant, plus eps multiples after usually after tax.
On the other hand 10x is much too low a multiple for a pharma company, 30x imo is conservative, so in the end $8 isn't that unrealistic.
Also anticipating a fair amount of dilution to come to fund the marketing campaign but there's clearly so much fat here that it won't matter in the end.
- Forums
- ASX - By Stock
- BOT
- Ann: Webinar Updated Commercial Research for Sofpironium Bromide
Ann: Webinar Updated Commercial Research for Sofpironium Bromide, page-17
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.0¢ | 37.5¢ | 36.5¢ | $309.0K | 837.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 20712 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 562676 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 91712 | 0.370 |
9 | 248230 | 0.365 |
10 | 369262 | 0.360 |
7 | 227411 | 0.355 |
7 | 478950 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 570229 | 16 |
0.380 | 765033 | 13 |
0.385 | 266589 | 10 |
0.390 | 354269 | 19 |
0.395 | 345620 | 8 |
Last trade - 10.58am 15/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online